共 435 条
[1]
Livshits G(2019)Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis Ageing Res Rev 56 913-89
[2]
Kalinkovich A(2018)Sarcopenia: assessment of disease burden and strategies to improve outcomes Clin Interv Aging 13 82-991S
[3]
Liguori I(2020)Association of muscle strength and gait speed with cross-sectional muscle area determined by mid-thigh computed tomography—a comparison with skeletal muscle mass measured by dual-energy X-ray absorptiometry J Frailty Aging 9 990S-90
[4]
Russo G(1997)Sarcopenia: origins and clinical relevance J Nutr 127 83-687
[5]
Aran L(2020)Differences in the prevalence of sarcopenia in community-dwelling, nursing home and hospitalized individuals. A systematic review and meta-analysis J Nutr Health Aging 24 674-114
[6]
Bulli G(2019)Sarcopenia and fatty liver disease Hepatol Int 13 109-27
[7]
Curcio F(2012)Sarcopenia in the elderly: diagnosis, physiopathology and treatment Maturitas 71 20-15
[8]
Della-Morte D(2018)Association of nutrition and immune-endocrine dysfunction with muscle mass and performance in cognitively impaired older adults Arch Gerontol Geriatr 75 10-63
[9]
Gargiulo G(2017)Inflammation and sarcopenia: a systematic review and meta-analysis Maturitas 96 57-143
[10]
Testa G(2020)Circulating interleukin-6 is associated with skeletal muscle strength, quality, and functional adaptation with exercise training in mobility-limited older adults J Frailty Aging 9 139-711